TONELLI, ROBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 19.665
AS - Asia 8.846
EU - Europa 8.241
SA - Sud America 1.375
Continente sconosciuto - Info sul continente non disponibili 374
AF - Africa 246
OC - Oceania 77
Totale 38.824
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 18.920
IT - Italia 3.595
SG - Singapore 2.772
CN - Cina 2.028
GB - Regno Unito 1.076
VN - Vietnam 1.007
BR - Brasile 989
HK - Hong Kong 886
DE - Germania 737
SE - Svezia 630
BD - Bangladesh 621
RU - Federazione Russa 415
CA - Canada 364
FI - Finlandia 338
FR - Francia 337
KR - Corea 253
IN - India 234
ID - Indonesia 221
NL - Olanda 198
AR - Argentina 145
JP - Giappone 140
TR - Turchia 138
UA - Ucraina 135
MX - Messico 129
ES - Italia 89
BG - Bulgaria 87
IE - Irlanda 84
PL - Polonia 77
IQ - Iraq 74
AU - Australia 70
CO - Colombia 70
ZA - Sudafrica 68
PK - Pakistan 63
LT - Lituania 59
AT - Austria 50
RO - Romania 50
CR - Costa Rica 49
CL - Cile 46
AE - Emirati Arabi Uniti 45
EC - Ecuador 44
BE - Belgio 42
IL - Israele 40
CH - Svizzera 33
VE - Venezuela 33
EG - Egitto 30
MA - Marocco 30
TW - Taiwan 30
CZ - Repubblica Ceca 29
MY - Malesia 29
SV - El Salvador 27
TH - Thailandia 27
JM - Giamaica 25
JO - Giordania 25
PH - Filippine 25
NI - Nicaragua 24
SA - Arabia Saudita 24
PR - Porto Rico 23
UZ - Uzbekistan 23
DZ - Algeria 21
HN - Honduras 21
KE - Kenya 20
SI - Slovenia 20
IR - Iran 19
PY - Paraguay 19
GR - Grecia 18
NP - Nepal 18
TT - Trinidad e Tobago 18
GT - Guatemala 17
TN - Tunisia 16
AZ - Azerbaigian 15
DK - Danimarca 15
GP - Guadalupe 15
NO - Norvegia 15
PE - Perù 15
SC - Seychelles 15
EE - Estonia 14
HU - Ungheria 14
PT - Portogallo 13
CW - ???statistics.table.value.countryCode.CW??? 12
RS - Serbia 12
KZ - Kazakistan 11
SN - Senegal 11
DO - Repubblica Dominicana 10
HR - Croazia 9
MD - Moldavia 9
OM - Oman 9
BH - Bahrain 8
AL - Albania 7
GE - Georgia 7
KG - Kirghizistan 7
LV - Lettonia 7
NZ - Nuova Zelanda 7
UY - Uruguay 7
BY - Bielorussia 6
GA - Gabon 6
LB - Libano 6
PA - Panama 6
QA - Qatar 6
SY - Repubblica araba siriana 6
AM - Armenia 5
Totale 38.364
Salva come PNG Salva come JPEG
Città #
Ashburn 2.440
Singapore 1.787
Santa Clara 1.551
San Jose 1.293
Fairfield 1.279
Council Bluffs 963
Hong Kong 853
Chandler 840
Woodbridge 599
Hefei 580
Houston 524
Seattle 484
Cambridge 409
Southend 399
New York 388
Beijing 384
Wilmington 372
London 363
Nyköping 349
Los Angeles 336
Milan 330
Ho Chi Minh City 325
Ann Arbor 307
Modena 278
Chicago 248
Helsinki 242
Seoul 232
Hanoi 228
San Diego 214
Rome 212
Bologna 209
Jakarta 188
The Dalles 173
Dallas 167
Dearborn 160
Munich 158
Jacksonville 131
Buffalo 113
Moscow 111
São Paulo 107
Shanghai 106
Lauterbourg 104
Princeton 103
Tokyo 103
Boardman 95
Toronto 92
Atlanta 84
Orem 84
Sofia 84
Naples 70
Redwood City 68
Dublin 64
Salt Lake City 63
Grafing 62
Montreal 62
Parma 62
Frankfurt am Main 60
Warsaw 56
Mexico City 55
Turin 55
Phoenix 51
Brooklyn 47
Chennai 47
Columbus 47
Elk Grove Village 47
Nuremberg 47
Verona 47
Mumbai 46
Bremen 45
Da Nang 44
Denver 44
Eugene 43
Florence 43
Lappeenranta 42
Poplar 41
Haiphong 39
Miami 39
Reggio Emilia 39
North York 38
Sydney 37
Rio de Janeiro 35
San José 35
Hangzhou 33
Johannesburg 33
Kent 33
Washington 33
Ankara 32
Brussels 32
Guangzhou 32
Hillsboro 32
North Bergen 32
Turku 32
Tampa 31
Baghdad 29
Boston 28
Izmir 28
Palermo 28
Redondo Beach 28
Stockholm 28
Amsterdam 27
Totale 23.352
Salva come PNG Salva come JPEG
Nome #
Cytomegalovirus blood reactivation in COVID-19 critically ill patients: risk factors and impact on mortality. 568
COVID-19-associated vasculitis and thrombotic complications: from pathological findings to multidisciplinary discussion 540
Tocilizumab in patients with severe COVID-19: a retrospective cohort study 486
Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with Covid-19 pneumonia. 462
Acute exacerbation of Idiopathic Pulmonary Fibrosis: lessons learned from the Acute Respiratory Distress Syndrome 458
Development and validation of a prediction model for tocilizumab failure in hospitalized patients with SARS-CoV-2 infection 452
Delirium and risk factors in patients undergoing non-invasive ventilation for de novo acute respiratory failure: an observational multicenter trial. 436
Insufficienza respiratoria acuta e cronica (cap.21). 432
Two fatal cases of acute liver failure due to HSV-1 infection in COVID-19 patients following immunomodulatory therapies. 429
Acute severe asthma: management and treatment. 426
Better prognosis in females with severe COVID-19 pneumonia: possible role of inflammation as potential mediator. 418
Machine learning in predicting respiratory failure in patients with COVID-19 pneumonia - challenges, strengths, and opportunities in a global health emergency. 415
Incidence, etiology and clinico-pathologic features of endobronchial benign lesions: 10 consecutive years rerospective study 400
Effectiveness of pulmonary rehabilitation in patients with INTERSTITIAL LUNG DISEASE of different etiology: a multicenter prospective study 400
Herpes Simplex re-activation in patients with SARS-CoV2 pneumonia: a prospective observational study. 396
Proteomics Analysis of Formalin-Fixed Paraffine-Embedded Tissue Reveals Key Proteins Related to Lung Dysfunction in Idiopathic Pulmonary Fibrosis. 395
An uncommon cause of hemoptysis: aortobronchial fistula. 388
Risk factors for pulmonary air leak and clinical prognosis in patients with COVID-19 related acute respiratory failure: a retrospective matched control study. 386
Comparison of Patients With or Without COVID-19 and Without Hematological Diseases Treated for Invasive Pulmonary Aspergillosis: A 5-Year Retrospective Cohort Study with Propensity-Based Adjustment 370
Prevalence and outcome of diaphragmatic dysfunction assessed by ultrasound technology during acute exacerbation of chronic obstructive pulmonary disease: a pilot study. 367
When Acute Respiratory Distress Syndrome is not ARDS 362
The effect of bronchodilators on forced vital capacity measurement in patients with idiopathic pulmonary fibrosis 362
First and second waves among hospitalised patients with COVID-19 with severe pneumonia: a comparison of 28-day mortality over the 1-year pandemic in a tertiary university hospital in Italy 360
Spontaneous breathing and evolving phenotypes of lung damage in patients with COVID-19. 358
Integrated intErventional bronchoscopy in the treatment of locally adVanced non-small lung cancER with central Malignant airway Obstructions: a multicentric REtrospective study (EVERMORE). 356
Acute exacerbation of interstitial lung diseases secondary to systemic rheumatic diseases: A prospective study and review of the literature 355
Hypokalemia in Patients with COVID-19 355
Molecular Mechanisms and Physiological Changes behind Benign Tracheal and Subglottic Stenosis in Adults 355
Optimization of intranasal bleomycin dose for effective pulmonary fibrosis induction in mice with minimal animal distress. 354
Breathlessness, but not cough, suggests chronic obstructive pulmonary disease in elderly smokers with stable heart failure 353
An uncommon cause of pneumonia: The golden diagnosis 349
Ventilatory support and mechanical properties of the fibrotic lung acting as a “squishy ball” 348
Serial Ultrasound Assessment of Diaphragmatic Function and Clinical Outcome in Patients with Amyotrophic Lateral Sclerosis. 347
Pulmonary stretch and lung mechanotransduction: Implications for progression in the fibrotic lung 347
Prevalence Of Subclinical Liver Fibrosis Among Patients With Idiopathic Pulmonary Fibrosis 345
Expression of HOXB7 in the lung of patients with idiopathic pulmonary fibrosis: a proof of concept study. 344
Molecular mechanisms and cellular contribution from lung fibrosis to lung cancer development. 344
Use of Pirfenidone in Idiopathic Pulmonary Fibrosis: A Case Study 342
Prevalence and development of chronic critical illness in acute patients admitted to a respiratory intensive care setting 340
Early inspiratory effort assessment by esophageal manometry early predicts noninvasive ventilation outcome in de novo respiratory failure: a pilot study. 332
Fibrotic idiopathic interstitial lung disease: the molecular and cellular key players. 332
Use of adjunctive cardiovascular therapy in patients hospitalized for acute exacerbations of COPD. 331
HRCT Patterns Of Usual Interstitial Pneumonia In Rheumatoid Lung 330
Breakthroughs in internal and respiratory medicine 325
Novel drug targets for idiopathic pulmonary fibrosis 325
Inspiratory effort and respiratory mechanics in spontaneously breathing patients with acute exacerbation of idiopathic pulmonary fibrosis: a retrospective matched control study. 325
Etiology and Level of Lung Derangement Do Not Affect the Beneficial Effect of Pulmonary Rehabilitation in Patients with Interstitial Lung Diseases 324
Peritoneal dialysis in the time of coronavirus disease 2019 322
Respiratory mechanics and diaphragmatic dysfunction in COPD patients who failed non-invasive mechanical ventilation 321
Subclinical liver fibrosis in patients with idiopathic pulmonary fibrosis 310
The Effect Of Bronchodilators On Forced Vital Capacity In Patients With Idiopathic Pulmonary Fibrosis 300
Early awake proning in critical and severe COVID-19 patients undergoing noninvasive respiratory support: A retrospective multicenter cohort study 300
Effect of high flow nasal oxygen on inspiratory effort of patients with acute hypoxic respiratory failure and do not intubate order. 298
Ultrasound assessment of diaphragmatic function in patients with amyotrophic lateral sclerosis. 298
Effects of cytokine blocking agents on hospital mortality in patients admitted to ICU with acute respiratory distress syndrome by SARS-CoV2 infection: retrospective cohort study. 298
COPD exacerbation and diaphragmatic dysfunction: Conditions with mutual influence influencing outcomes? - Reply. 297
Ultrasound assessed Diaphragm Impairment is a Predictor of Outcomes in Acute Exacerbation of Chronic Obstructive Pulmonary Disease undergoing Non-Invasive Ventilation. 296
High flow nasal therapy versus noninvasive ventilation as initial ventilatory strategy in COPD exacerbation: a multicenter non-inferiority randomized trial 295
Proprietà meccaniche e comportamento elastico del polmone affetto da fibrosi con pattern "polmonite interstiziale tipica" in corso di ventilazione meccanica: sviluppo e significato clinico della teoria del polmone "squishy ball" 295
COVIDGuide una app per il triage e l'autovalutazione della COVID-19. 288
Real-life comparison of Pirfenidone and Nintedanib in patients with Idiopathic Pulmonary Fibrosis: a 24-month assessment. 286
Looking for a Chronic Care Model in COPD patients 283
Atypical diagnosis for typical lung carcinoid 280
Never Give Up: lesson learned from a severe COVID-19 patient. 279
Nasal pressure swings as the measure of inspiratory effort in spontaneously breathing patients with de novo acute respiratory failure 278
The encaged lung: rapidly progressive idiopathic pleurisy. 277
STenting veRsus balloOn dilatation in patients with tracheal BEnign stenosis – the STROBE trial. 277
Endobronchial valve positioning for alveolar-pleural fistula following ICU management of severe COVID-19 pneumonia. 276
The performance of the GAP model in patients with rheumatoid arthritis associated interstitial lung disease 272
Inspiratory effort and lung mechanics in spontaneously breathing patients with acute respiratory failure due to COVID-19. A matched control study. 267
Biological effects of COVID-19 on lung cancer: can we drive our decisions? 263
RHEUMATOID ARTHRITIS RELATED INTERSTITIAL LUNG DISEASE. RADIOLOGICAL PATTERNS AND CORRELATIONS WITH CLINICAL, SEROLOGICAL AND DEMOGRAPHIC FEATURES OF DISEASE 262
Impact of Mesenchymal Stromal/stem Cell Infusions on Circulating Inflammatory Biomarkers in COVID-19 Patients: Analysis of a Phase I-IIa Trial. 257
Dissecting the role of mesenchymal stem cells in idiopathic pulmonary fibrosis: cause or solution? 254
Idiopathic pulmonary fibrosis: diagnostic pitfalls and therapeutic challenges. 253
Endoscopic Bronchopleural Fistula Repair Using Autologous Fat Graft 253
Changes in clinical characteristics and outcomes of patients admitted to inpatient cardiac rehabilitation 251
Janus-faced amiodarone-induced pneumopathy 249
Assessing respiratory drive and inspiratory effort in critically ill patients at the bedside 248
Surfactant replacement might help recovery of low-compliance lung in severe COVID-19 pneumonia. 248
Differences between acute exacerbations of idiopathic pulmonary fibrosis and other interstitial lung diseases. 245
The association of procalcitonin and C- reactive protein with bacterial infections acquired during ICU stay in COVID-19 critically ill patients. 244
An Italian sacrifice to COVID-19 epidemic. 242
Awaiting a cure for COVID-19: therapeutic approach in patients with different severity levels of COVID-19 242
Response Letter to Tuffet S, et al. and to Michard F, et al. 240
Physiological effects of lung protective ventilation in patients with lung fibrosis and usual interstitial pneumonia pattern versus primary ARDS: a matched-control study. 239
Impaired function in the complex patient with COPD: a matter to be considered 238
Monitoring and modulation of respiratory drive in patients with acute hypoxemic respiratory failure in spontaneous breathing 237
Vanishing lung emphysema during chemotherapy for malignant pleural mesothelioma. 235
The role of immune response in the pathogenesis of idiopathic pulmonary fibrosis: far beyond the Th1/Th2 imbalance. 233
An umbrella review of systematic reviews with meta-analyses evaluating positive and negative outcomes of Hydroxychloroquine and chloroquine therapy 233
Association Between Pulmonary Aspergillosis And Cytomegalovirus Reactivation In Critically Ill Covid-19 Patients: A Prospective Observational Cohort Study. 232
Erratum: Acute exacerbation of interstitial lung diseases secondary to systemic rheumatic diseases: A prospective study and review of the literature (Journal of Thoracic Disease (2019) 11 (1621-1628) DOI: 10.21037/jtd.2019.03.28) 232
Accuracy of nasal pressure swing to predict failure of high flow nasal oxygen in patients with acute hypoxemic respiratory failure 230
Do All Critically Ill Patients with COVID-19 Disease Benefit from Adding Tocilizumab to Glucocorticoids? A Retrospective Cohort Study 229
Development of clinical tools to estimate the breathing effort during high-flow oxygen therapy: A multicenter cohort study 227
Multicentre match-paired analysis of advanced biliary cancer long-term survivors: The BILONG study 226
Correction: Endobronchial valve positioning for alveolar-pleural fistula following ICU management complicating COVID-19 pneumonia (BMC Pulmonary Medicine, (2021), 21, 1, (307), 10.1186/s12890-021-01653-w) 226
Association between respiratory distress time and invasive mechanical ventilation in COVID-19 patients: a multicentre regional cohort study. 223
Unusual effectiveness of systemic steroids in Whipple disease. 222
Totale 31.830
Salva come PNG Salva come JPEG
Categoria #
all - tutte 154.063
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 154.063
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.222 0 0 0 0 160 201 195 175 486 220 459 326
2022/20232.874 346 363 250 281 279 361 94 274 334 57 124 111
2023/20242.367 68 110 182 223 330 243 278 242 102 120 189 280
2024/20256.252 178 123 143 455 1.077 919 515 410 684 318 576 854
2025/202613.611 971 566 999 1.576 1.848 778 1.561 683 1.269 1.331 1.170 859
2026/20275.409 563 1.857 1.039 1.602 348 0 0 0 0 0 0 0
Totale 38.824